Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in moderate to severe hidradenitis suppurativa
NCT01704534Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- May 2012
- Primary completion
- Jan 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ustekinumab in hidradenitis suppurativa (HS), sponsored by University Medical Center Groningen. Started May 2012; status: completed.
02
Drugs
ustekinumab
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT01704534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01704534.